Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 9;194:105162. doi: 10.1016/j.antiviral.2021.105162

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 7 — Effect of PPCM on SARS-CoV-2-induced immune response in SAEC. Shown are cytokine/chemokine levels in mock- and virus (MOI 0.1)-infected SAEC cells, with or without PPCM treatment at day 4 pi. Results are expressed as averages of data from biological triplicates, and bars represent standard deviations. *, p < 0.05; **, p < 0.01; ***; p < 0.001 (ANOVA, Tukey's test). Note that statistical differences between cytokine/chemokine levels in mock-infected cells with and without PPCM treatment are not highlighted in this figure.